Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05513092
Other study ID # 10544
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date August 2022
Est. completion date July 2024

Study information

Verified date August 2022
Source Ain Shams University
Contact sahar M abdelmaksoud, masters
Phone 01110065637
Email saharabdelmaksoud@yahoo.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

role of placenta accreta index score in prediction of conservative surgery for placenta placenta accreta spectrum


Description:

in this study ,we will recruit 60 cases diagnosed placenta previa accreta by 2D ultrasound and Doppler then patients will have 3D Doppler to calculate placenta accreta index score according to agarawl et al criteria , patients will have cs accroding to our hospital protocol "Al demerdash maternity hospital ,Ainshams university" .Intraoperative findings will be noticed ,postoperative histopathological examination may br needed in cases of cs hystrectomy ,placenta accreta index score will be compared to intra and postoperative findings , patients will be followed up for two weeks after delivery for any postoperative complication


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date July 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - • Pregnant women above 28 weeks gestation by 1st trimesteric U/S,2nd trimesteric U/S or sure reliable dates; diagnosed as placenta previa by 2D ultrasound, Doppler on placental bed. - Patients who have done one or more cesarean sections Exclusion Criteria: - Patients who refuse to participate in our study.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
placenta accreta index score
role of placenta accreta index score in prediction of conservative surgery for placenta placenta accreta spectrum

Locations

Country Name City State
Egypt Ainshams university Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of PAS index score in prediction of conservative surgery 2022 to 2024
Secondary Intraoperative blood loss at delivery
See also
  Status Clinical Trial Phase
Recruiting NCT05376410 - Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum
Recruiting NCT03813212 - Magnetic Resonance Imaging (MRI ) Versus Ultrasound in Placenta Accreta Diagnosis
Not yet recruiting NCT05191316 - the Efficacy and Safety of the 3-steps Conservative Approach in the Management of Placenta Accreta Spectrum (a Novel Technique)
Completed NCT05945446 - A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies
Recruiting NCT03947047 - Detection of Placenta Accreta Via Exhaled Women Breath